PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days
Condition(s):Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2Last Updated:April 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2Last Updated:April 1, 2021Completed
Condition(s):Diabetic Nephropathies; Type 1 Diabetes Mellitus; Chronic Kidney DiseasesLast Updated:August 5, 2022Completed
Condition(s):Diabetes MellitusLast Updated:June 6, 2018Completed
Condition(s):Diabetes MellitusLast Updated:August 30, 2023Completed
Condition(s):Healthy SubjectsLast Updated:August 11, 2017Completed
Condition(s):Type 1 DiabetesLast Updated:November 20, 2012Terminated
Condition(s):Diabetes Mellitus; Surgical Procedure, UnspecifiedLast Updated:April 7, 2023Completed
Condition(s):Diabetes Mellitus, Type 1Last Updated:May 6, 2023Completed
Condition(s):Diabetes MellitusLast Updated:January 21, 2016Completed
Condition(s):Type 1 DiabetesLast Updated:February 28, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.